Unicycive Therapeutics, Inc. UNCY

4.70 (0.11) (2.29%) as of 25 Sep
Market cap
$134.0M
P/E
0.0×
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
— — — —

+8 more quarters

EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
3.81 2.40 2.59 3.83
Net Debt/EBITDA
6.13 6.65 5.84 5.93
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(0.28) (0.26) (0.51) (0.33)
Book value per Share
1.98 1.58 1.90 2.07
Free Cash Flow
(7.60) (6.25) (8.03) (5.96)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates